Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Total Liabilities
Everything the company owes to creditors and other parties.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.34B USD | -4.1% | +11.4% | 81.1% | |
| Mar 2026 | $554.64M USD | -29.6% | -14.2% | 45.9% | |
| Mar 2026 | $547.71M USD | +88.6% | +125.5% | 186.5% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -4.1% | +11.4% | 81.1% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.